stockrowPerrigo Company plc
PRGO Healthcare Drug Manufacturers Specialty & Generic
Perrigo Company plc’s revenue for fiscal 2025 (year ended December 2025) was $4.3 billion, down 2.75% from fiscal 2024.
- Revenue
- −5.24%
- EPS
- −494.6%
- Free cash flow
- +138.5%
- Total debt
- −9.62%
Quarter to September 2026, against a year earlier
Follow PRGO
Alert me
Perrigo Company plc (PRGO) Shares outstanding
Perrigo Company plc's shares outstanding at the end of fiscal 2025 was $138.5M, unchanged from fiscal 2024. At the end of the quarter to 30 September 2026 it was $139.4M. Over the past ten years it has ranged from $133.6M (fiscal 2021) to $146.1M (fiscal 2015); the current reading is higher than 67% of that period. Perrigo Company plc ranks 22nd of 81 Drug Manufacturers Specialty & Generic companies by shares outstanding.
Shares outstanding, annual
Embed this chart
Annual newest first
| Period | Shares outstanding | Change |
|---|---|---|
| FY2025 | $138.5M | 0.80% |
| FY2024 | $137.4M | 1.55% |
| FY2023 | $135.3M | 0.59% |
| FY2022 | $134.5M | 0.67% |
| FY2021 | $133.6M | (2.62%) |
| FY2020 | $137.2M | 0.51% |
| FY2019 | $136.5M | (1.30%) |
| FY2018 | $138.3M | (3.02%) |
| FY2017 | $142.6M | (0.49%) |
| FY2016 | $143.3M | (1.92%) |
Quarterly newest first
| Period | Shares outstanding | Change |
|---|---|---|
| Sep 2026 | $139.4M | (0.14%) |
| Jun 2026 | $139.6M | 0.65% |
| Mar 2026 | $138.7M | 0.14% |
| Dec 2025 | $138.5M | (0.29%) |
| 43 more quarters | Free account |
Against its own ten years
Shares outstanding against peers
| Company | Shares outstanding |
|---|---|
| ALVO Alvotech compare | $295.0M |
| BCRX BioCryst Pharmaceuticals, Inc. compare | $267.6M |
| HCM HUTCHMED (China) Limited Sponsored ADR compare | $214.3M |
| TRLV Trulieve Cannabis Corp. compare | $200.6M |
| XERS Xeris Biopharma Holdings, Inc. compare | $189.9M |
| PRGO Perrigo Company plc | $139.4M |
| PBH Prestige Consumer Healthcare Inc. compare | $47.6M |
| ANIP ANI Pharmaceuticals, Inc. compare | $21.7M |
| RGC Regencell Bioscience Holdings Limited compare | — |
What Shares outstanding is
Shares (Diluted, Weighted) tells an investor how many shares a company’s earnings are spread across once potential new shares are counted.
Reported line item
More on PRGO
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement